Orphenadrine Citrate, Aspirin and Caffeine (Rebel Distributors Corp)
Welcome to the PulseAid listing for the Orphenadrine Citrate, Aspirin and Caffeine drug offered from Rebel Distributors Corp. This Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rebel Distributors Corp |
| NON-PROPRIETARY NAME: | Orphenadrine Citrate, Aspirin and Caffeine |
| SUBSTANCE NAME: | ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, MULTILAYER |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1996-12-31 |
| END MARKETING DATE: | 0000-00-00 |
Orphenadrine Citrate, Aspirin and Caffeine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Orphenadrine Citrate, Aspirin and Caffeine from Rebel Distributors Corp |
| LABELER NAME: | Rebel Distributors Corp |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50; 770; 60(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 1996-12-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 21695-726_8e41b33e-f71f-4a5e-b88f-cdfefb2bee20 |
| PRODUCT NDC: | 21695-726 |
| APPLICATION NUMBER: | ANDA074654 |
Other ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE Pharmaceutical Manufacturers / Labelers:
